Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells.

× No keyword cloud information.

9 in total

1. Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor.

Authors: R L Sutherland; C K Watts; P C Ruenitz
Journal: Biochem Biophys Res Commun Date: 1986-10-30 Impact factor: 3.575

2. Post-transcriptional regulation of the human transforming growth factor-beta 1 gene.

Authors: S J Kim; K Park; D Koeller; K Y Kim; L M Wakefield; M B Sporn; A B Roberts
Journal: J Biol Chem Date: 1992-07-05 Impact factor: 5.157

3. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

Authors: A Butta; K MacLennan; K C Flanders; N P Sacks; I Smith; A McKinna; M Dowsett; L M Wakefield; M B Sporn; M Baum
Journal: Cancer Res Date: 1992-08-01 Impact factor: 12.701

4. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.

Authors: D A Bronzert; G L Greene; M E Lippman
Journal: Endocrinology Date: 1985-10 Impact factor: 4.736

5. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

Authors: C Knabbe; M E Lippman; L M Wakefield; K C Flanders; A Kasid; R Derynck; R B Dickson
Journal: Cell Date: 1987-02-13 Impact factor: 41.582

6. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.

Authors: A A Colletta; L M Wakefield; F V Howell; K E van Roozendaal; D Danielpour; S R Ebbs; M B Sporn; M Baum
Journal: Br J Cancer Date: 1990-09 Impact factor: 7.640

7. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

Authors: A M Thompson; D J Kerr; C M Steel
Journal: Br J Cancer Date: 1991-04 Impact factor: 7.640

8. Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

Authors: J MacCallum; J M Bartlett; A M Thompson; J C Keen; J M Dixon; W R Miller
Journal: Br J Cancer Date: 1994-06 Impact factor: 7.640

9. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.

Authors: R R Perry; Y Kang; B R Greaves
Journal: Br J Cancer Date: 1995-12 Impact factor: 7.640

9 in total

4 in total

1. Protein modification by thiolactone homocysteine chemistry: a multifunctionalized human serum albumin theranostic.

Authors: Tatyana V Popova; Olesya A Krumkacheva; Anna S Burmakova; Anna S Spitsyna; Olga D Zakharova; Vladimir A Lisitskiy; Igor A Kirilyuk; Vladimir N Silnikov; Michael K Bowman; Elena G Bagryanskaya; Tatyana S Godovikova
Journal: RSC Med Chem Date: 2020-04-02

2. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.

Authors: G Pan; S M Vickers; A Pickens; J O Phillips; W Ying; J A Thompson; G P Siegal; J M McDonald
Journal: Am J Pathol Date: 1999-07 Impact factor: 4.307

3. Estradiol in females may negate skeletal muscle myostatin mRNA expression and serum myostatin propeptide levels after eccentric muscle contractions.

Authors: Darryn S Willoughby; Colin D Wilborn
Journal: J Sports Sci Med Date: 2006-12-15 Impact factor: 2.988

4. Tamoxifen Action in ER-Negative Breast Cancer.

Authors: Subrata Manna; Marina K Holz
Journal: Sign Transduct Insights Date: 2016-02-10

4 in total